CCA
CEMI

Conestoga Capital Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Conestoga Capital Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-123,155
Closed -$631K – 150
2020
Q1 		$631K Buy
123,155
+7,080
+6% +$28.6K 0.02% 85
2019
Q4 		$529K Buy
116,075
+87,075
+300% +$424K 0.01% 110
2019
Q3 		$177K Buy
+29,000
New +$173K ﹤0.01% 141

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Conestoga Capital Advisors's CEMI Position: Q2 2020 in Review

Conestoga Capital Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 123,155 shares — an estimated $631K sold.

Conestoga Capital Advisors first reported a position in CEMI in Q3 2019 and held it in 3 quarters. The position peaked at $631K in Q1 2020. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

  • Conestoga Capital Advisors reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Conestoga Capital Advisors sold 123,155 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $631K.
  • Conestoga Capital Advisors first reported a position in Chembio diagnostics, Inc. in Q3 2019 and held it in 3 quarters.
  • Conestoga Capital Advisors's Chembio diagnostics, Inc. position peaked at $631K in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on Conestoga Capital Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.